Research map: Prospective comparison of 99mTc-PSMA and 99mTc-MDP scintigraphy for detection of skeletal metastases in treatment-naïve patients with unfavorable intermediate-, high-, and very high-risk prostate cancer

Back to the article

Papers in this map

  1. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study · Michael S. Hofman · 2020 · 2057 citations · Cited by this paper
  2. Italian association of nuclear medicine molecular imaging and therapy (AIMN) practical guide on white blood cells labelling for imaging infections and inflammations: technical procedure, quality controls and national regulations · 2026 · Related
  3. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer · Thomas Pyka · 2016 · 375 citations · Cited by this paper
  4. Technical and clinical recommendations for [¹⁸F]FDOPA PET/CT in oncologic applications · 2026 · Related
  5. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) · Robert Seifert · 2023 · 315 citations · Cited by this paper
  6. The effect of semi-automatic segmentation approaches on semi-quantitative parameters of 68Ga-Pentixafor PET-CT in newly diagnosed multiple myeloma patients · 2026 · Related
  7. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis · Kit Mun Chow · 2023 · 191 citations · Cited by this paper
  8. [18F]fluorocholine PET/CT in primary hyperparathyroidism is costly but worth the cost · 2026 · Related
  9. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer · Werner Langsteger · 2016 · 125 citations · Cited by this paper
  10. Why density really matters: advancing molecular breast imaging with sinogram-domain deep learning · 2026 · Related
  11. Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT · Guillermina Ferro‐Flores · 2017 · 81 citations · Cited by this paper
  12. The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors · 2025 · Related
  13. Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal System · Joseph Kabunda · 2021 · 36 citations · Cited by this paper
  14. Technical research advances in PET radionuclide tracers for diagnosing hepatocellular carcinoma · 2026 · Related
  15. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers · Thomas A. Hope · 2023 · 34 citations · Cited by this paper
  16. Clinical study on bile excretion pattern of [18F]AlF-FAPI-74 and measures to eliminate its physiological uptake in the hepatobiliary system · 2025 · Related
  17. Imaging Prostate Cancer: Clinical Utility of Prostate-Specific Membrane Antigen · David Kuppermann · 2022 · 33 citations · Cited by this paper
  18. [99mTc]Tc-Octreotide SPECT-based radiomics analysis for predicting response in patients with neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE PRRT: a multicenter study on Ki-67 index and grade discordance · 2025 · Related
  19. Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial · Yu Zhang · 2022 · 31 citations · Cited by this paper
  20. Radiomics in preclinical imaging: current trends and future directions · 2026 · Related
  21. Prostate Cancer in Latin America: Challenges and Recommendations · Rodolfo Borges dos Reis · 2020 · 26 citations · Cited by this paper
  22. Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis · Qi Wang · 2024 · 21 citations · Cited by this paper
  23. [99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas · Paola Vallejo-Armenta · 2021 · 20 citations · Cited by this paper
  24. The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review · Xu Zhang · 2023 · 20 citations · Cited by this paper
  25. A 2022 International Survey on the Status of Prostate Cancer Theranostics · Thomas Beyer · 2022 · 15 citations · Cited by this paper
  26. Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT · Joel E. Vargas-Ahumada · 2023 · 12 citations · Cited by this paper
  27. Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review · Rohit Srinivasan · 2024 · 10 citations · Cited by this paper
  28. Comparing the role of 99mTc-HYNIC-PSMA-11 and 99mTc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer · Tahereh Ghaedian · 2023 · 8 citations · Cited by this paper
  29. Lethal Prostate Cancer in Mexico: Data from the Can.Prost Mexican Registry and a Project for Early Detection · Miguel Angel Jimenez Rios · 2024 · 6 citations · Cited by this paper
  30. Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases · Erik Rud · 2022 · 5 citations · Cited by this paper
  31. Incidental Diagnosis of Metastatic Breast Cancer in a Man With 99mTc-PSMA SPECT/CT · César D. Zárate-García · 2023 · 5 citations · Cited by this paper
  32. 68 Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study · Juliano J. Cerci · 2025 · 5 citations · Cited by this paper
  33. Prostate-specific membrane antigen PET versus [99mTc]Tc-MDP bone scan for diagnosing bone metastasis in prostate cancer: a head-to-head comparative meta-analysis · Yiming Wang · 2024 · 4 citations · Cited by this paper
  34. Prostate Adenocarcinoma Recurrence in the Vas Deferens Unveiled by 99mTc-PSMA SPECT/CT Imaging · Nasrin Raeisi · 2025 · 3 citations · Cited by this paper
  35. Detection rate of [99mTc]Tc-PSMA SPECT/CT in prostate cancer: a systematic review and a meta-analysis · Domenico Albano · 2026 · 3 citations · Cited by this paper
  36. Intraindividual comparison of 99mTc-HYNIC-PSMA-11 and 99mTc-MDP bone scan with SPECT/CT for detecting skeletal metastases in prostate cancer: a prospective concordance study · Sameer Kamalakar Taywade · 2025 · 2 citations · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)